DPH.L

Dechra Pharmaceuticals Plc
FTSE Russell - Dechra Pharmaceuticals
11th January 2024, 18:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 4516Z
FTSE Russell
11 January 2024
 

 


 

Further to the FTSE notice released on 09 January 2024 in relation to Dechra Pharmaceuticals (UK): Constituent Deletion,  please note the replacement in the fixed indices.

 

All other details remain unchanged. Please see updated notice below:

 

Dechra Pharmaceuticals (UK): Constituent Deletion - Update
Changes in FTSE UK Index Series

11 January 2024

Subject to court sanctioning the scheme of arrangement in relation to the cash offer for Dechra Pharmaceuticals (UK, constituent) by Freya Bidco Limited (non-constituent), please see details of affected indexes and effective dates below:

 

Dechra Pharmaceuticals (UK, 0963318) will be deleted from the index.

 

Persimmon PLC (UK, 0682538) will be added to the FTSE 100 Index and deleted from the FTSE 250 Index.

 

Baillie Gifford US Growth Trust (UK, BDFGHW4) will be added to the FTSE 250 Index and deleted from the FTSE SmallCap Index.

 

All changes effective from 16 January 2024

 

Full details of index changes are available on the FTSE Russell website.

 

 

 

 

 

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:


Australia


+61 (0) 2 7228 5659

Hong Kong

+852 2164 3333

Japan

+81 3 6441 1430

London

+44 (0) 20 7866 1810

New York

+1877 503 6437

                                   

 

Alternatively please visit our website at lseg.com/ftse-russell

 


 Terms of Use | Copyright © 2024 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSFLFLDLIILLIS]]>
TwitterFacebookLinkedIn